Premium
Atea Pharmaceuticals Inc (AVIR)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
| Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Return on Assets (%) | -127.16 | -2.472 | 14.811 | -16.198 | -21.552 |
| Return on Equity (%) | 56.622 | -4.394 | 19.269 | -17.265 | -22.74 |
| Return on Invested Capital (%) | -150.435 | -3.89 | 19.244 | -18.878 | -27.755 |
| Operating Margin (%) | N/A | -22.509 | 39.443 | N/A | N/A |
| Net Profit Margin (%) | N/A | -22.509 | 34.491 | N/A | N/A |
| Book Value Per Share | 1.937 | 10.322 | 8.545 | 7.691 | 6.654 |
| Earnings Per Share | -1.391 | -0.206 | 1.458 | -1.4 | -1.629 |
| Cash Per Share | 2.147 | 16.019 | 9.198 | 2.263 | 1.724 |
| Working Capital Per Share | 1.93 | 10.32 | 8.61 | 7.714 | 6.689 |
| Operating Profit Per Share | N/A | 0.916 | 4.228 | N/A | N/A |
| EBIT Per Share | -1.391 | -0.206 | 1.668 | -1.435 | -1.617 |
| EBITDA Per Share | -1.391 | -0.206 | 1.668 | -1.435 | -1.617 |
| Free Cash Flow Per Share | -1.392 | -0.206 | 1.458 | -1.38 | -1.634 |
| Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
| Actions en circulation | 10,09M | 53,07M | 83,1M | 83,29M | N/A |
| Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
|---|---|---|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||||
| Actions en circulation | 83,29M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Capitalisation boursière | 288,86M |
| Ratio cours/bénéfice | -2,19 |
| Ratio prix/ventes | 0 |
| Ratio prix/liquidités | 2,07 |
| Ratio prix/valeur comptable | 0,54 |
| Rendement de dividende | - |
| Actions en circulation | 84,46M |
| Volume moyen (1 semaine) | 435,78k |
| Volume moyen (1 mois) | 566,23k |
| Variation sur 52 semaines | 10,59% |
| Plus haut sur 52 semaines | 4,60 |
| Plus bas sur 52 semaines | 2,30 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
